President Trump announced that Pfizer will lower prescription drug prices for Medicaid and introduced a “TrumpRx” website aimed at offering discounted medications directly to Americans, especially low-income individuals, by early 2026. This initiative follows an executive order establishing “most favored nation” pricing, aiming to align U.S. drug costs with international rates and includes Pfizer’s commitment to significant U.S. manufacturing investment.